EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy and Potential Mechanisms of Naringin in Atopic Dermatitis

Seung-Ah Yoo, Ki-Chan Kim iD, Ji-Hyun Lee iD

International Journal of Molecular Sciences · 15.10.2024 · 25 (20) · 11064

DOI: 10.3390/ijms252011064 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.10.2024. Verfasst von Seung-Ah Yoo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Flavanones. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Seoul St. Mary's Hospital, The Catholic University of Korea, Research Fund of Seoul St. Mary’s Hospital, The Catholic University of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atopic dermatitis (AD) is one of the most prevalent chronic inflammatory skin diseases. Topical treatments are recommended for all patients regardless of severity, making it essential to develop an effective topical AD treatment with minimal side effects; We investigated the efficacy of topical application of naringin in AD and explored the possible mechanisms using an AD mouse model induced by 1-chloro-2,4-dinitrobenzene (DNCB). Clinical, histological, and immunological changes related to AD and Janus kinase (JAK)-signal transducer and activator of transcription (STAT) signaling proteins in the skin tissues were measured as outcomes; Naringin treatment resulted in a significant improvement in dermatitis severity score and reduced epidermal thickness and mast cell count in the skin (p < 0.05). Naringin also demonstrated the ability to inhibit DNCB-induced changes in interleukin (IL) 4, chemokine (C-C motif) ligand (CCL) 17, CCL22, IL1β, interferon-gamma (IFN-γ), and tumor necrosis factor-alpha (TNF-α) levels by quantitative real-time polymerase chain reaction (qRT-PCR) and IL13 by enzyme-linked immunosorbent assay (ELISA) (p < 0.05). Western blot results exhibited the decreased JAK1, JAK2, STAT1, STAT3, phospho-STAT3, and STAT6 expression in the naringin-treated groups (p < 0.05); The findings of this study suggest that topical naringin may effectively improve the symptoms of AD and could be used as a therapeutic agent for AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicFlavanonesAnimalsMiceDisease Models, AnimalDinitrochlorobenzeneSignal TransductionCytokinesMice, Inbred BALB CFemaleSkinSTAT Transcription FactorsMast Cells

Stichwörter der Autor:innen

atopic dermatitisflavonoidsinflammationnaringin

Substanzen

naringinFlavanonesDinitrochlorobenzeneCytokinesSTAT Transcription Factors

Autor:innen und Institutionen

  • Department of Dermatology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
  • Department of Medical Sciences, Graduate School of The Catholic University of Korea, Seoul 06591, Republic of Korea.

ORCID-Profile: Ki-Chan Kim, Ji-Hyun Lee

Förderung

  • Seoul St. Mary's Hospital, The Catholic University of Korea
  • Research Fund of Seoul St. Mary’s Hospital, The Catholic University of Korea

Zitieren

APA

Yoo, S. A., Kim, K. C., & Lee, J. H. (2024). Efficacy and Potential Mechanisms of Naringin in Atopic Dermatitis. International Journal of Molecular Sciences, 25(20), 11064. https://doi.org/10.3390/ijms252011064

Vancouver

Yoo SA, Kim KC, Lee JH. Efficacy and Potential Mechanisms of Naringin in Atopic Dermatitis. International Journal of Molecular Sciences. 2024;25(20):11064. doi:10.3390/ijms252011064

BibTeX
@article{Yoo2024,
  author = {Yoo, Seung-Ah and Kim, Ki-Chan and Lee, Ji-Hyun},
  title = {Efficacy and Potential Mechanisms of Naringin in Atopic Dermatitis},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {20},
  pages = {11064},
  doi = {10.3390/ijms252011064}
}
Kostenlos starten →